The DOI matches its Crossref record.
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
Abstract
Type 2 diabetes is associated with increased circulating concentrations of markers of the acute-phase response and interleukin-6 (IL-6). An augmented acute-phase response may be a mechanism which explains many of the clinical and biochemical features of type 2 diabetes and its complications. We sought to confirm that circulating concentrations of the cytokine acute-phase mediators IL-6 and tumour necrosis factor alpha [TNFalpha] are elevated in type 2 diabetes, and investigated blood as a source of cytokines in type 2 diabetes. Blood samples from 20 type 2 diabetic and 17 age-matched healthy subjects were incubated in vitro for 24 hr with and without lipopolysaccharide (LPS) stimulation and secreted cytokines measured. Plasma IL-6 and TNFalpha were significantly increased in type 2 diabetes compared to normal subjects. However, basal production of IL-6 and TNFalpha in cultured diabetic blood was markedly depressed in comparison with non-diabetic samples. IL-6 and TNFalpha production was increased in blood in response to LPS, reaching similar levels in diabetic and non-diabetic subjects, though IL-6 was slightly but significantly higher in controls. We conclude that circulating levels of IL-6 and TNFalpha are increased in type 2 diabetes but there is downregulation of basal cytokine production in blood cells in type 2 diabetes. Blood has the capacity to produce cytokines in diabetes which contribute to the augmented acute-phase response, but the main source of the increased plasma IL-6 and TNFalpha concentrations may be from non-circulating cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interleukin-6 is produced by many cell types including macrophages, adipose cells, and skeletal muscle, and circulating levels are increased in type 2 diabetes (53,54).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [54]
In the citing paper
“Interleukin-6 is produced by many cell types including macrophages, adipose cells, and skeletal muscle, and circulating levels are increased in type 2 diabetes (53,54).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [54]
Citations
Cited by
Sorted by citations
Items 201–300 of 566
Esmaeili, M. H., Enayati, M., Khabbaz, F., Ebrahimian, F., & Salari, A. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112359 · Cited by 61
Lechleitner, M., Herold, M., Dzien‐Bischinger, C., Hoppichler, F., & Dzien, A. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00846.x · Cited by 59
Pache, J., Kastrati, A., Mehilli, J., Bollwein, H., Ndrepepa, G., Schühlen, H., Martinoff, S. A., Seyfarth, M., Nekolla, S. G., Dirschinger, J., et al. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.01.019 · Cited by 59
Diabetes causes marked changes in lymphocyte metabolism
Otton, R., Mendonca, & Curi, R. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740055 · Cited by 59
“Type 2 diabetic patients show reduced thymidine uptake by lymphocytes, a reduced percentage of IL-2 receptorpositive cells and increased plasma levels of tumour necrosis factor- when compared with controls (Pavelic et al. 1987, Chang & Shaio 1995, Pickup et al. 2000).”
ResultLecube, A., Hernández, C., Genescà, J., Esteban, J. I., Jardí, R., García, L., & Simó, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2669 · Cited by 59
Peng, L., Chen, Y., Shi, S., & Wen, H. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02696-w · Cited by 59
Değirmenci, İ., Özbayer, C., Kebapçı, M. N., Kurt, H., Çolak, E., & Güneş, H. V. (2019) · Inflammation Research · doi:10.1007/s00011-019-01263-7 · Cited by 60
Sherry, C. L., O’Connor, J. C., Kramer, J. M., & Freund, G. G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.663 · Cited by 59
Role of clinical pathologies in myocardial injury following ischaemia and reperfusion
Galiñanes, M. (2003) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.028 · Cited by 56
How does neurovascular unit dysfunction contribute to multiple sclerosis?
Cashion, J. M., Young, K. M., & Sutherland, B. A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106028 · Cited by 58
“Increased oxidative stress and chronic inflammation [increased TNFα (tumour necrosis factor alpha) and IL (interleukin)-6], drive vascular dysfunction in obesity (Kalousová et al., 2002; Pickup et al., 2000).”
BackgroundThe Role of Transforming Growth Factor-Beta in Diabetic Nephropathy
Gomes, K. B., Rodrigues, K. F., & Fernandes, A. P. (2014) · International Journal of Medical Genetics · doi:10.1155/2014/180270 · Cited by 56
Jorquera, G., Russell‐Guzmán, J., Monsalves‐Álvarez, M., Cruz, G., Valladares-Ide, D., Basualto-Alarcón, C., Barrientos, G. C., Estrada, M., & Llanos, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063254 · Cited by 61
Effects of crocin on experimental obesity and type-2 diabetes
Hazman, Ö., Aksoy, L., & Büyükben, A. (2016) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1506-108 · Cited by 55
The structural and functional changes of blood cells and molecular components in diabetes mellitus
Szablewski, L., & Sulima-Celińska, A. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0196 · Cited by 57
TNF‐α polymorphisms and type 2 diabetes mellitus in Taiwanese patients
Shiau, M.-Y., Wu, C., Huang, C., Hu, S., Lin, S., & Chang, Y.-H. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00059.x · Cited by 53
Јovanović, J. A., Mihailović, M., Bogojević, D., Ivanović‐Matić, S., Uskoković, A. S., Poznanović, G., & Grigorov, I. (2012) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-012-0186-7 · Cited by 53
Singla, D. K., Singla, R. D., Abdelli, L. S., & Glass, C. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120739 · Cited by 53
Bagi, Z. A., Brosková, Z., & Fehér, A. (2014) · Current Vascular Pharmacology · doi:10.2174/1570161112666140423221843 · Cited by 52
“Elevated plasma resistin is correlated with levels of inflammatory markers, including soluble TNF receptor-2, IL-6, and lipoprotein-associated phospholipase A2 along with increased coronary calcium score – a measure of the severity of coronary sclerosis – in 879 asymptomatic subjects [63].”
BackgroundInfluentialDerakhshan, R., Arababadi, M. K., Ahmadi, Z., Karimabad, M. N., Salehabad, V. A., Abedinzadeh, M., Khorramdelazad, H., Balaei, P., Kennedy, D. D., & Hassanshahi, G. (2011) · Inflammation · doi:10.1007/s10753-011-9391-8 · Cited by 53
“Increased serum levels of inflammatory cytokines including IL-18 [8], IL-6 [9], IL-17 [10], IFN-γ [10], and TNF-α [9] have been documented in type 2 diabetes and its nephropathic complications.”
InfluentialSakowicz‐Burkiewicz, M., Kocbuch, K., Grdeń, M., et al. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02380.x · Cited by 51
Inflammation and pathogenesis of diabetic nephropathy
Mora, C., & Navarro‐González, J. F. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.005 · Cited by 51
Stress Insulin Resistance is a Marker for Mortality in Traumatic Brain Injury
Mowery, N. T., Gunter, O. L., Guillamondegui, O. M., Dossett, L. A., Dortch, M. J., Morris, J. A., & May, A. K. (2009) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181938c5e · Cited by 50
Association Between Diabetes Mellitus and Outcomes of Patients with Sepsis: A Meta-Analysis
Wang, Z. P., Ren, J., Wang, G., Liu, Q., Guo, K., & Li, J. (2017) · Medical Science Monitor · doi:10.12659/msm.903144 · Cited by 54
“In terms of inflammation cytokines, it has been reported that levels of plasma interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF alpha) are increased in patients with DM [24,25], whereas a downregulation of basal cytokine production could be noticed in blood cells in type 2 diabetes patients.”
BackgroundArababadi, M. K., Mirzaei, P., Sajadi, S. M. A., Hassanshahi, G., Ahmadabadi, B. N., Salehabad, V. A., Derakhshan, R., & Kennedy, D. D. (2011) · Inflammation · doi:10.1007/s10753-011-9376-7 · Cited by 48
Elgouhari, H. M., Zein, C. O., Hanouneh, I. A., et al. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0683-2 · Cited by 48
Yang, Y., Liu, L., Liu, B., Li, Q., Wang, Z., Fan, S.-Y., Wang, H., & Wang, L. (2018) · DNA and Cell Biology · doi:10.1089/dna.2017.4005 · Cited by 49
“These include increased serum levels of pro-inflammatory cytokines interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha), which can mediate monocyte and macrophage inflammation in the adipose tissue, and elevated inflammatory marker C-reactive protein (CRP), which is produced in the liver under cytokine sti…”
BackgroundDevelopment of aldose reductase inhibitors for the treatment of inflammatory disorders
Chatzopoulou, M., Pegklidou, K., Papastavrou, N., & Demopoulos, V. J. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.843524 · Cited by 48
“This elevation is highly related to increased blood glucose, decreased glucose tolerance and decreased insulin sensitivity [39,40].”
BackgroundVisentin, S., Lapolla, A., Londero, A. P., Cosma, C., Dalfrà, M., Camerin, M., Faggian, D., Plebani, M., & Cosmi, E. (2014) · BioMed Research International · doi:10.1155/2014/401595 · Cited by 47
Adipose tissue macrophages as a therapeutic target in obesity‐associated diseases
Herrada, A. A., Olate‐Briones, A., Armando Rojas, R., Liu, C., Escobedo, N., & Piesche, M. (2021) · Obesity Reviews · doi:10.1111/obr.13200 · Cited by 48
Lindmark, S., Burén, J., & Eriksson, J. W. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02593.x · Cited by 45
Paik, J. K., Kim, O. Y., Koh, S. J., Jang, Y., Chae, J. S., Kim, J. Y., Kim, H. J., Hyun, Y. J., Cho, J. R., & Lee, J. H. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.11.011 · Cited by 44
Ramana, K. V., Tammali, R., Reddy, A. B. M., Bhatnagar, A., & Sk, S. (2007) · Endocrinology · doi:10.1210/en.2007-0512 · Cited by 45
Neutrophils and their role in the aetiopathogenesis of type 1 and type 2 diabetes
Giovenzana, A., Carnovale, D., Phillips, B. E., Petrelli, A., & Giannoukakis, N. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3483 · Cited by 44
“This is suggestive of an exhausted phenotype, likely as a result of the chronic stimulation mediated by high levels of pro‐inflammatory molecules in patient sera.(166) Defective NETosis in T2D appears to”
BackgroundB cells as under-appreciated mediators of non-auto-immune inflammatory disease
Nikolajczyk, B. S. (2010) · Cytokine · doi:10.1016/j.cyto.2010.02.022 · Cited by 42
“In addition to its pro-inflammatory roles, elevated serum IL-6 probably plays roles in glucose metabolism through stimulation of skeletal muscle [104,105].”
BackgroundVolpe, C. M. O., Abreu, L. F. M., Gomes, P. S., Gonzaga, R. M., Veloso, C. A., & Nogueira‐Machado, J. A. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/479587 · Cited by 45
New Insights Into the Use of Biomarkers of Diabetic Nephropathy
Jha, J. C., Jandeleit-Dahm, K. A. M., & Cooper, M. E. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.03.008 · Cited by 44
Townsend, L. K., Medak, K. D., Peppler, W. T., Meers, G. M.-E., Rector, R. S., LeBlanc, P. J., & Wright, D. C. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m092510 · Cited by 44
Elsayed, R. H., Kamel, E. M., Mahmoud, A. M., El‐Bassuony, A. A., Bin-Jumah, M. N., Lamsabhi, A. M., & Ahmed, S. A. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111202 · Cited by 47
Boonloh, K., Kukongviriyapan, U., Pannangpetch, P., Kongyingyoes, B., Senggunprai, L., Prawan, A., Thawornchinsombut, S., & Kukongviriyapan, V. (2014) · Food & Function · doi:10.1039/c4fo00872c · Cited by 43
Germoush, M. O., Elgebaly, H. A., Hassan, S. M., Kamel, E. M., Bin-Jumah, M. N., & Mahmoud, A. M. (2019) · Antioxidants · doi:10.3390/antiox9010022 · Cited by 46
“In this context, increased circulating levels of interleukin (IL)-6 and tumor necrosis factor (TNF)-α have been demonstrated in T2DM in human patients [13] as well as rodents [14,15].”
BackgroundKajitani, N., Shikata, K., Nakamura, A., Nakatou, T., Hiramatsu, M., & Makino, H. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.01.012 · Cited by 43
Sente, T., Van Berendoncks, A. M., Fransen, E., Vrints, C. J., & Hoymans, V. Y. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00831.2015 · Cited by 41
“Diabetes is known to be associated with elevated levels of TNF(36).”
BackgroundSerum hepcidin concentrations and type 2 diabetes
Aregbesola, A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i7.978 · Cited by 41
Impaired Inflammatory Response to LPS in Type 2 Diabetes Mellitus
Khondkaryan, L., Margaryan, S., Poghosyan, D., & Manukyan, G. P. (2018) · International Journal of Inflammation · doi:10.1155/2018/2157434 · Cited by 41
“No difference between diabetic and healthy subjects in the production of TNFα and IL10 upon LPS treatment have been found [36, 40], while in study by Geerlings et al.”
BackgroundIshii, H., Ichimiya, S., Kanashiro, M., Amano, T., Matsubara, T., & Murohara, T. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1588 · Cited by 41
Johnson, D. R., O’Connor, J. C., Dantzer, R., & Freund, G. G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507191102 · Cited by 40
Fatima, N., Faisal, S. M., Zubair, S., Siddiqui, S. S., Moin, S., & Owais, M. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.07.155 · Cited by 32
El‐Sherbini, S. M., Shahen, S. M., Mosaad, Y. M., Abdelgawad, M. S., & Talaat, R. M. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt003 · Cited by 42
Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals
Gumieniczek, A., Hopkała, H., Roliński, J., & Bojarska-Junak, A. A. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.02.019 · Cited by 39
Insulin-like growth factor binding protein-3 mediates cytokine-induced mesangial cell apoptosis
Vasylyeva, T. L., Chen, X., & Ferry, R. J. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2005.02.008 · Cited by 38
“Serum levels of pro-inflammatory cytokines, particularly tumor necrosis factor (TNF)-α, are significantly higher in patients with type 2 diabetes and correlate to progression of DN [16-19].”
BackgroundHernández, J. J. C., Almeida, M. D. G., Burgo, R. M., Hernández, P., Miralles, J. M., & Órfão, A. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.09.006 · Cited by 37
Fontaine‐Bisson, B., Wolever, T. M. S., Chiasson, J., RABASA-LHORET, R. P. R., Maheux, P., Josse, R. G., Leiter, L. A., Rodger, N. W., Ryan, E. A., & El‐Sohemy, A. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.013 · Cited by 36
“Obese and diabetic individuals have elevated plasma levels of tumor necrosis factor a (TNF-a), a multifunctional regulatory cytokine involved in the inflammatory response [2,3].”
BackgroundInterleukin-4 gene polymorphisms in type 2 diabetic patients with nephropathy.
Arababadi, M. K. (2010) · PubMed · Cited by 37
Significance of CXCL12 in Type 2 Diabetes Mellitus and Its Associated Complications
Karimabad, M. N., & Hassanshahi, G. (2014) · Inflammation · doi:10.1007/s10753-014-9981-3 · Cited by 36
“Moreover, elevated serum levels of inflammatory cytokines including interleukin-18 (IL-18), interleukin-6 (IL-6), interleukin-17 (IL-17), interferon gamma (IFN-γ), and tumor necrosis factor alpha (TNF-α) have been reported in T2D [7, 11, 12].”
BackgroundWilson, C. G., Schupp, M., Burkhardt, B. R., et al. (2010) · Endocrinology · doi:10.1210/en.2010-0379 · Cited by 36
Jung, T. W., Chung, Y. H., Kim, H., El‐Aty, A. M. A., & Jeong, J. H. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00408.2017 · Cited by 37
Cell therapy of critical limb ischemia in diabetic patients – State of art
Dubský, M., Jirkovská, A., Bém, R., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.02.028 · Cited by 35
Mechanism and Potential of Egg Consumption and Egg Bioactive Components on Type-2 Diabetes
Wang, X., Son, M., Chalamaiah, M., & Wu, J. (2019) · Nutrients · doi:10.3390/nu11020357 · Cited by 38
Inflammatory cytokines in insulin-treated patients with type 2 diabetes
Mavridis, G., Souliou, E., Diza, E., Symeonidis, G., Pastore, F., Vassiliou, A. M., & Karamitsos, D. T. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.02.013 · Cited by 35
Elevated Interleukin-17 Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Chen, C., & Shao, Y. (2016) · Biochemistry & Physiology Open Access · doi:10.4172/2168-9652.1000206 · Cited by 34
“Elevated concentrations of various inflammatory markers such as tumor necrosis factor-α (TNF-α) and interleukin (IL)-6 and IL-1β have been reported in patients with type 2 diabetes [14-16].”
BackgroundFyr, C. L. W., Kanaya, A., Cummings, S., Reich, D., Hsueh, W., Reiner, A., Harris, T., Moffett, S., Li, R.-L., Ding, J.-Z., et al. (2007) · Human Genetics · doi:10.1007/s00439-007-0353-z · Cited by 38
“2006a), tumor necrosis factor (TNF)(Pickup et al. 2000; Winkler et al. 1998), C-reactive protein (CRP) (Pradhan et al.”
BackgroundAraya, A. V., Pavez, V., Perez, C., Gonzalez, F., Columbo, A., Aguirre, A., Schiattino, I., & Aguillón, J. C. (2003) · PubMed · Cited by 35
The role of diet-derived short-chain fatty acids in regulating cardiac pressure overload
Pakhomov, N. V., & Baugh, J. A. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00573.2020 · Cited by 34
Rytter, E., Vessby, B. O., Åsgård, R., Ersson, C., Moussavian, S., Sjödin, A. M., Abramsson-Zetterberg, L., Möller, L., & Basu, S. (2010) · Free Radical Research · doi:10.3109/10715762.2010.515219 · Cited by 34
Nutritional Influences on Inflammation and Type 2 Diabetes Risk
Browning, L. M., & Jebb, S. A. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.45 · Cited by 36
Zhang, Q., Olatunji, O. J., Chen, H., Tola, A. J., & Oluwaniyi, O. O. (2018) · Chemistry & Biodiversity · doi:10.1002/cbdv.201800219 · Cited by 33
“Plasma concentrations of inflammatory molecules, including pro-inflammatory cytokines, are elevated in diabetic patients.([37]) In our present study, we observed that elevated levels of TNF-a, IL-6 and IL-1b in the diabetic control rats but on treatment with SHF, a dosedependent significant reduction of the serum leve…”
BackgroundMoringa oleifera leaves ethanolic extract ameliorates high fat diet-induced obesity in rats
El‐Shehawi, A. M., Alkafafy, M., El-Shazly, S. A., Sayed, S. M. H., Farouk, S., Alotaibi, S. S., Madkour, D. A., Khalifa, H. K., & Ahmed, M. M. (2021) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2021.101552 · Cited by 33
Hua, K., Wang, S., Dong, W.-C., et al. (2012) · Inflammation Research · doi:10.1007/s00011-012-0503-1 · Cited by 33
“Plasma cytokines were significantly increased in subjects with T2D compared to normal subjects [2, 3].”
Evaluation of IFN-γ Serum Level in Nephropatic Type 2 Diabetic Patients
Nosratabad, R., Arababadi, M. K., Hassanshah, G., Yaghini, N., Pooladvand, V., Shamsizadeh, A., Zarandi, E. R., & Hakimi, H. (2009) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2009.746.749 · Cited by 33
Dangwal, S., Rauch, B. H., Gensch, T., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.219105 · Cited by 33
Park, C. S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i22.6835 · Cited by 32
Espinoza, S. E., Jiwani, R. B., Wang, J., & Wang, C.-P. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.01.006 · Cited by 32
Intricate role of oxidative stress in the progression of obesity
Nijhawan, P., Arora, S., & Behl, T. (2019) · Obesity Medicine · doi:10.1016/j.obmed.2019.100125 · Cited by 35
The deleterious effect of high concentrations of D-glucose requires pro-inflammatory preconditioning
Lafuente, N., Matesanz, N., Azcutia, V., Romacho, T., Nevado, J. B., Rodríguez‐Mañas, L., Moncada, S., Peiró, C., & Sánchez‐Ferrer, C. F. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f331fb · Cited by 31
Surgery Is Preferred for the Diabetic With Multivessel Disease
King, S. B. (2005) · Circulation · doi:10.1161/circulationaha.104.483339 · Cited by 29
Matumba, M. G., Ayeleso, A. O., Nyakudya, T. T., Erlwanger, K. H., Chegou, N. N., & Mukwevho, E. (2019) · Nutrients · doi:10.3390/nu11020226 · Cited by 31
“These results are consistent with other previous studies showing that inflammatory cytokine markers are elevated in insulin resistance and obese individuals [6,15,16,19,37].”
BackgroundResultFlaxseed orbitides, linusorbs, inhibit LPS-induced THP-1 macrophage inflammation
Zou, X., Shim, Y. Y., Cho, J. Y., Jeong, D., Yang, J. P., Deng, Z., & Reaney, M. J. T. (2020) · RSC Advances · doi:10.1039/c9ra09058d · Cited by 29
Magalhães, N. S., Savino, W., Silva, P., Martins, M. A., & Carvalho, V. F. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.644751 · Cited by 30
Liu, K., Luo, T., Zhang, Z., Wang, T., Kou, J., Liu, B., & Huang, F. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.01.051 · Cited by 30
Dual PPAR α/γ Agonists: Promises and Pitfalls in Type 2 Diabetes
Ahmed, I., Furlong, K., Flood, J. J., Treat, V., & Goldstein, B. J. (2007) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000212890.82339.8d · Cited by 30
Song, Y., Miyaki, K., Araki, J., Zhang, L., Omae, K., & Muramatsu, M. (2007) · Metabolism · doi:10.1016/j.metabol.2007.02.006 · Cited by 30
“On the other hand, circulating IL-6 levels have been shown to be elevated in T2DM [16,17] or to contribute xperimental 56 (2007) 925–930”
BackgroundBain, J. L., Lester, S. R., Henry, W. D., Bishop, C. M., Turnage, A. A., Naftel, J. P., & Johnson, R. B. (2009) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2008.01110.x · Cited by 30
Eskandarani, R., & Sawan, S. (2020) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551420984125 · Cited by 29
Foss‐Freitas, M. C., Foss, N. T., Donadi, E. A., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1375.027 · Cited by 29
Circulating dendritic cell number and intracellular TNF-α production in women with type 2 diabetes
Blank, S. E., Johnson, E. C., Weeks, D. K., & Wysham, C. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0190-8 · Cited by 30
Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction
Terlecki, M., Bednarek, A., Kawecka−Jaszcz, K., Czarnecka, D., & Bryniarski, L. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0038 · Cited by 29
“Increased levels of inflammation markers such as C-reactive protein and tumour necrosis factor alpha, increased activation of adhesive molecules, increased leukocyte number and their cytotoxic activity, and increased synthesis of free oxygen radicals are often observed in ACS patients with hyperglycaemia in the acute…”
BackgroundAkbari, M., & Hassan‐Zadeh, V. (2018) · Immunological Investigations · doi:10.1080/08820139.2018.1480031 · Cited by 29
Down-Regulation of Insulin Signaling Is Involved in Painful Diabetic Neuropathy in Type 2 Diabetes
Li, Y.-Q. (2013) · Pain Physician · doi:10.36076/ppj.2013/16/e71 · Cited by 30
Peiró, C., Matesanz, N., Nevado, J., et al. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705483 · Cited by 29
“Interestingly, circulating levels of TNF-a have been shown to be elevated in both type I and type II diabetic subjects (Lechleitner et al., 2000; Pickup et al., 2000), and a positive association has been found between plasma levels of TNF-a and cardiovascular risk factors in type I diabetes…”
BackgroundSakowicz‐Burkiewicz, M. (2004) · International Immunology · doi:10.1093/intimm/dxh195 · Cited by 29
Abduh, M. S., Alzoghaibi, M. A., Alzoghaibi, A. M., Bin‐Ammar, A., Alotaibi, M., Kamel, E. M., & Mahmoud, A. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121612 · Cited by 29
Mengozzi, A., Ciuceis, C. D., Dell’Oro, R., Georgiopoulos, G. A., Lazaridis, A. A., Nosalski, R., Pavlidis, G., Tual‐Chalot, S., Rosei, C. A., Anyfanti, P., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003503 · Cited by 32
“Studies have demonstrated that inflammatory mediators, such as CRP, TNF-a, IL-6 and IL-18, have elevated expression in DM [168,169].”
BackgroundRahman, A., Cope, M. B., Sarker, S. A., et al. (2009) · Journal of Life Sciences · doi:10.1080/09751270.2009.11885133 · Cited by 28
“Insulin resistance was determined by the Homeostasis Model Assessment (HOMA-IR) according to the formula: HOMA-IR = [fasting glucose (millimoles per liter) x fasting insulin (milliunits per liter)]/22.5.”
InfluentialInflammation, Aging, and Adiposity
Addison, O. R., LaStayo, P. C., Dibble, L. E., & Marcus, R. L. (2011) · Journal of Geriatric Physical Therapy · doi:10.1519/jpt.0b013e3182312b14 · Cited by 28
Children and adolescents with obesity-associated high blood pressure
Falkner, B. E. (2008) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2008.01.003 · Cited by 27
Navarro‐González, J. F., Fernández, C. M., Gómez-Chinchón, M., Muros, M., Herrera, H., & Garcı́a, J. G. (2010) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201002300105 · Cited by 27
Yang, J., Kan, M., & Wu, G. Y. (2016) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2016.1142560 · Cited by 28
Firouzi, S. S., Sarvestani, N. N., Bakhtiarian, A., et al. (2018) · Neurological Research · doi:10.1080/01616412.2018.1458813 · Cited by 27
The 2012 SEMDSA Guideline for the Management of type 2 Diabetes
(2012) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2012.10872277 · Cited by 28
“Eur J Clin Invest 2004; 34(8): 535-542 21.”
Uskoković, A. S., Mihailović, M., Dinić, S., Јovanović, J. A., Grdović, N., Marković, J., Poznanović, G., & Vidaković, M. (2013) · Journal of Functional Foods · doi:10.1016/j.jff.2013.09.018 · Cited by 26
Metadata
- Authors
- Pickup, J. C., Chusney, G. D., Thomas, S. M., & Burt, D.
- Affiliations
- Guy's Hospital (GB)
- Corresponding author
- Pickup, John C.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2000-06
- Volume
- 67
- Issue
- 3
- Pages
- 291-300
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2084483597
- Cited by
- 566
- References
- 0
- Citations by year
- 2026: 4 · 2025: 19 · 2024: 18 · 2023: 21 · 2022: 13 · 2021: 23 · 2020: 26 · 2019: 20 · 2018: 20 · 2017: 17 · 2016: 24 · 2015: 25 · 2014: 35 · 2013: 29 · 2012: 21
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Life Sciences (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Bupa Foundation
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
- Keywords
- type 2 diabetes, interleukin-6, TNF-α, acute phase response, lipopolysaccharide stimulation, plasma cytokines, cytokine downregulation, inflammation in diabetes
- MeSH terms
- Acute-Phase Reaction, Diabetes Mellitus, Type 2, Female, Humans, Immunoenzyme Techniques, Lipopolysaccharides, Male, Middle Aged, Tumor Necrosis Factor-alpha, Interleukin-6, N-Acetylneuraminic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review